Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitors
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitors
Authors
Keywords
-
Journal
BLOOD
Volume 123, Issue 9, Pages 1341-1352
Publisher
American Society of Hematology
Online
2014-01-11
DOI
10.1182/blood-2013-03-488114
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A stable transcription factor complex nucleated by oligomeric AML1–ETO controls leukaemogenesis
- (2013) Xiao-Jian Sun et al. NATURE
- PRMT1 interacts with AML1-ETO to promote its transcriptional activation and progenitor cell proliferative potential
- (2012) W.-J. Shia et al. BLOOD
- Valproic acid induces differentiation and transient tumor regression, but spares leukemia-initiating activity in mouse models of APL
- (2012) M Leiva et al. LEUKEMIA
- Epigenetic protein families: a new frontier for drug discovery
- (2012) Cheryl H. Arrowsmith et al. NATURE REVIEWS DRUG DISCOVERY
- Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management
- (2011) Elihu H. Estey AMERICAN JOURNAL OF HEMATOLOGY
- Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma
- (2011) R. L. Piekarz et al. BLOOD
- Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
- (2011) Marcus Bantscheff et al. NATURE BIOTECHNOLOGY
- Cancer epigenetics reaches mainstream oncology
- (2011) Manuel Rodríguez-Paredes et al. NATURE MEDICINE
- The Leukemogenicity of AML1-ETO Is Dependent on Site-Specific Lysine Acetylation
- (2011) L. Wang et al. SCIENCE
- Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma
- (2010) Sean J. Whittaker et al. JOURNAL OF CLINICAL ONCOLOGY
- The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacy
- (2009) L. Ellis et al. BLOOD
- Development of the pan-DAC inhibitor panobinostat (LBH589): Successes and challenges
- (2009) Peter Atadja CANCER LETTERS
- Mouse models of human AML accurately predict chemotherapy response
- (2009) J. Zuber et al. GENES & DEVELOPMENT
- Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
- (2009) Richard L. Piekarz et al. JOURNAL OF CLINICAL ONCOLOGY
- Multivalent Binding of the ETO Corepressor to E Proteins Facilitates Dual Repression Controls Targeting Chromatin and the Basal Transcription Machinery
- (2009) C. Guo et al. MOLECULAR AND CELLULAR BIOLOGY
- Oncogenic RAS Enables DNA Damage- and p53-Dependent Differentiation of Acute Myeloid Leukemia Cells in Response to Chemotherapy
- (2009) Mona Meyer et al. PLoS One
- Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia
- (2009) J. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
- (2009) C. Choudhary et al. SCIENCE
- Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors
- (2008) Nagma Khan et al. BIOCHEMICAL JOURNAL
- Acute promyelocytic leukemia: from highly fatal to highly curable
- (2008) Z.-Y. Wang et al. BLOOD
- Histone Deacetylase Inhibitor Romidepsin Has Differential Activity in Core Binding Factor Acute Myeloid Leukemia
- (2008) O. M. Odenike et al. CLINICAL CANCER RESEARCH
- Histone Deacetylase Inhibitor Panobinostat Induces Clinical Responses with Associated Alterations in Gene Expression Profiles in Cutaneous T-Cell Lymphoma
- (2008) L. Ellis et al. CLINICAL CANCER RESEARCH
- Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype
- (2008) C Haferlach et al. LEUKEMIA
- MS-275, a novel histone deacetylase inhibitor with selectivity against HDAC1, induces degradation of FLT3 via inhibition of chaperone function of heat shock protein 90 in AML cells
- (2008) Chie Nishioka et al. LEUKEMIA RESEARCH
- Characterisation of the novel apoptotic and therapeutic activities of the histone deacetylase inhibitor romidepsin
- (2008) A. Newbold et al. MOLECULAR CANCER THERAPEUTICS
- Lysine Acetylation: Codified Crosstalk with Other Posttranslational Modifications
- (2008) Xiang-Jiao Yang et al. MOLECULAR CELL
- Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation
- (2008) Rihab Nasr et al. NATURE MEDICINE
- The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men
- (2008) Xiang-Jiao Yang et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Epigenetics in Cancer
- (2008) Manel Esteller NEW ENGLAND JOURNAL OF MEDICINE
- Complementing mutations in core binding factor leukemias: from mouse models to clinical applications
- (2008) A M S Müller et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started